$1.79 Billion is the total value of Eventide Asset Management's 139 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 14.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | CELGENE CORP | $70,303,000 | -16.4% | 702,400 | 0.0% | 3.93% | -6.6% | |
| PANW | PALO ALTO NETWORKS INC | $59,301,000 | -7.4% | 363,500 | 0.0% | 3.31% | +3.6% | |
| LOW | LOWES COS INC | $55,328,000 | -0.4% | 730,400 | 0.0% | 3.09% | +11.4% | |
| LRCX | Buy | LAM RESEARCH CORP | $55,028,000 | +4.3% | 666,200 | +0.3% | 3.08% | +16.6% |
| XPO | XPO LOGISTICS INC | $49,682,000 | +12.7% | 1,618,300 | 0.0% | 2.78% | +26.0% | |
| LEA | LEAR CORP | $48,804,000 | -9.5% | 439,000 | 0.0% | 2.73% | +1.2% | |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $47,920,000 | -6.6% | 710,555 | +0.5% | 2.68% | +4.4% |
| ABBV | Sell | ABBVIE INC | $47,207,000 | -6.6% | 826,452 | -3.2% | 2.64% | +4.4% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $46,936,000 | -9.9% | 1,155,200 | -8.0% | 2.62% | +0.7% |
| RHT | RED HAT INC | $46,315,000 | -10.0% | 621,600 | 0.0% | 2.59% | +0.6% | |
| KAR | Buy | KAR AUCTION SVCS INC | $45,898,000 | +3.4% | 1,203,400 | +0.4% | 2.56% | +15.6% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $45,374,000 | +0.4% | 524,550 | +0.4% | 2.54% | +12.3% |
| STLD | STEEL DYNAMICS INC | $34,114,000 | +26.0% | 1,515,500 | 0.0% | 1.91% | +40.8% | |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $33,855,000 | +15.4% | 1,865,278 | +74.9% | 1.89% | +29.1% |
| MBBYF | MOBILEYE N V AMSTELVEEN | $32,584,000 | -11.8% | 873,800 | 0.0% | 1.82% | -1.4% | |
| SPLK | SPLUNK INC | $32,206,000 | -16.8% | 658,200 | 0.0% | 1.80% | -7.0% | |
| ASML | ASML HOLDING NV | $31,392,000 | +13.1% | 312,700 | 0.0% | 1.75% | +26.5% | |
| MGA | Buy | MAGNA INTL INC | $31,352,000 | +6.4% | 729,800 | +0.5% | 1.75% | +18.9% |
| SYNA | SYNAPTICS INC | $31,138,000 | -0.7% | 390,500 | 0.0% | 1.74% | +11.0% | |
| CYBR | Sell | CYBERARK SOFTWARE LTD | $29,841,000 | -19.7% | 700,000 | -15.0% | 1.67% | -10.2% |
| SGEN | Buy | SEATTLE GENETICS INC | $29,318,000 | +19.8% | 835,506 | +53.2% | 1.64% | +33.9% |
| QLIK | QLIK TECHNOLOGIES INC | $29,088,000 | -8.7% | 1,005,800 | 0.0% | 1.62% | +2.1% | |
| CPN | CALPINE CORP | $27,955,000 | +4.8% | 1,842,800 | 0.0% | 1.56% | +17.2% | |
| ATHN | Buy | ATHENAHEALTH INC | $27,923,000 | +5.6% | 201,200 | +22.5% | 1.56% | +18.1% |
| WAB | WABTEC CORP | $27,752,000 | +11.5% | 350,000 | 0.0% | 1.55% | +24.7% | |
| WBC | WABCO HLDGS INC | $27,329,000 | +4.6% | 255,600 | 0.0% | 1.53% | +16.8% | |
| IPHI | INPHI CORP | $26,642,000 | +23.4% | 799,100 | 0.0% | 1.49% | +38.0% | |
| PFPT | PROOFPOINT INC | $26,508,000 | -17.3% | 492,900 | 0.0% | 1.48% | -7.6% | |
| TSLA | TESLA MTRS INC | $25,344,000 | -4.3% | 110,300 | 0.0% | 1.42% | +7.0% | |
| EXR | Sell | EXTRA SPACE STORAGE INC | $23,365,000 | -51.0% | 250,000 | -53.7% | 1.31% | -45.2% |
| BLUE | BLUEBIRD BIO INC | $22,929,000 | -33.8% | 539,500 | 0.0% | 1.28% | -26.0% | |
| SPWR | SUNPOWER CORP | $22,340,000 | -25.6% | 1,000,000 | 0.0% | 1.25% | -16.8% | |
| MDVN | MEDIVATION INC | $22,259,000 | -4.9% | 484,100 | 0.0% | 1.24% | +6.3% | |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $21,395,000 | -22.4% | 1,046,700 | 0.0% | 1.20% | -13.3% | |
| LOXO | Buy | LOXO ONCOLOGY INC | $20,232,000 | +28.5% | 740,000 | +33.7% | 1.13% | +43.6% |
| BWA | BORGWARNER INC | $18,893,000 | -11.2% | 492,000 | 0.0% | 1.06% | -0.7% | |
| CRUS | CIRRUS LOGIC INC | $18,205,000 | +23.3% | 500,000 | 0.0% | 1.02% | +37.8% | |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $18,019,000 | +42.5% | 662,700 | +56.4% | 1.01% | +59.3% |
| CBI | CHICAGO BRIDGE & IRON CO N V | $17,871,000 | -6.2% | 488,400 | 0.0% | 1.00% | +4.9% | |
| STKL | SUNOPTA INC | $17,093,000 | -34.8% | 3,832,600 | 0.0% | 0.96% | -27.1% | |
| DATA | TABLEAU SOFTWARE INCcl a | $17,091,000 | -51.3% | 372,600 | 0.0% | 0.96% | -45.6% | |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $16,611,000 | -7.9% | 1,129,996 | +1.1% | 0.93% | +2.9% |
| IMPV | IMPERVA INC | $16,256,000 | -20.2% | 321,900 | 0.0% | 0.91% | -10.9% | |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $16,238,000 | +89.9% | 851,500 | +108.2% | 0.91% | +112.4% |
| UFS | DOMTAR CORP | $16,200,000 | +9.6% | 400,000 | 0.0% | 0.90% | +22.5% | |
| ABY | Buy | ABENGOA YIELD PLC | $16,091,000 | +27.3% | 905,000 | +38.1% | 0.90% | +42.2% |
| MGNX | MACROGENICS INC | $13,609,000 | -39.5% | 725,800 | 0.0% | 0.76% | -32.4% | |
| LLTC | LINEAR TECHNOLOGY CORP | $13,038,000 | +4.9% | 292,600 | 0.0% | 0.73% | +17.4% | |
| AGIO | AGIOS PHARMACEUTICALS INC | $12,212,000 | -37.5% | 300,800 | 0.0% | 0.68% | -30.1% | |
| VCYT | VERACYTE INC | $12,161,000 | -25.0% | 2,252,000 | 0.0% | 0.68% | -16.0% | |
| ORA | Buy | ORMAT TECHNOLOGIES INC | $11,562,000 | +111.3% | 280,359 | +86.9% | 0.65% | +136.6% |
| CSIQ | CANADIAN SOLAR INC | $11,568,000 | -33.4% | 600,000 | 0.0% | 0.65% | -25.7% | |
| NVAX | NOVAVAX INC | $11,247,000 | -38.5% | 2,179,700 | 0.0% | 0.63% | -31.3% | |
| XLRN | Buy | ACCELERON PHARMA INC | $11,176,000 | +85.6% | 423,500 | +242.9% | 0.62% | +107.3% |
| AYR | AIRCASTLE LTD | $9,532,000 | +6.5% | 428,600 | 0.0% | 0.53% | +19.0% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $9,358,000 | -21.6% | 334,700 | 0.0% | 0.52% | -12.2% | |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $8,769,000 | +31.0% | 575,000 | +15.5% | 0.49% | +46.3% |
| LGND | LIGAND PHARMACEUTICALS INC | $8,567,000 | -1.2% | 80,000 | 0.0% | 0.48% | +10.4% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $8,124,000 | -10.4% | 249,600 | 0.0% | 0.45% | +0.2% | |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $8,017,000 | -67.3% | 393,000 | -17.4% | 0.45% | -63.4% |
| TSRO | TESARO INC | $7,925,000 | -15.9% | 180,000 | 0.0% | 0.44% | -5.9% | |
| New | ESSA PHARMA INC | $7,826,000 | – | 2,719,410 | +100.0% | 0.44% | – | |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $7,015,000 | +321.3% | 365,000 | +314.8% | 0.39% | +372.3% |
| FSLR | New | FIRST SOLAR INC | $6,847,000 | – | 100,000 | +100.0% | 0.38% | – |
| KITE | KITE PHARMA INC | $6,822,000 | -25.5% | 148,600 | 0.0% | 0.38% | -16.8% | |
| SRPT | SAREPTA THERAPEUTICS INC | $6,486,000 | -49.4% | 332,300 | 0.0% | 0.36% | -43.5% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,186,000 | -21.3% | 75,000 | 0.0% | 0.35% | -12.0% | |
| CERN | CERNER CORP | $5,730,000 | -12.0% | 108,200 | 0.0% | 0.32% | -1.5% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $5,690,000 | -22.0% | 1,708,600 | 0.0% | 0.32% | -12.9% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $5,649,000 | -33.3% | 90,000 | 0.0% | 0.32% | -25.5% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $5,533,000 | -43.6% | 87,400 | 0.0% | 0.31% | -36.9% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $5,450,000 | -25.7% | 170,000 | +35.0% | 0.30% | -16.9% |
| GWPH | GW PHARMACEUTICALS PLCads | $5,303,000 | +3.9% | 73,500 | 0.0% | 0.30% | +16.1% | |
| PRTA | Buy | PROTHENA CORP PLC | $4,939,000 | -30.8% | 120,000 | +14.5% | 0.28% | -22.7% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $4,944,000 | -30.1% | 125,000 | 0.0% | 0.28% | -21.8% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $4,810,000 | -20.4% | 250,000 | 0.0% | 0.27% | -10.9% | |
| MCRB | SERES THERAPEUTICS INC | $4,733,000 | -24.3% | 178,200 | 0.0% | 0.26% | -15.7% | |
| XNCR | XENCOR INC | $4,616,000 | -8.2% | 344,000 | 0.0% | 0.26% | +2.8% | |
| TGTX | TG THERAPEUTICS INC | $4,580,000 | -28.6% | 537,600 | 0.0% | 0.26% | -20.2% | |
| BPMC | BLUEPRINT MEDICINES CORP | $4,449,000 | -31.5% | 246,500 | 0.0% | 0.25% | -23.4% | |
| ONCE | SPARK THERAPEUTICS INC | $4,427,000 | -34.9% | 150,000 | 0.0% | 0.25% | -27.4% | |
| STML | STEMLINE THERAPEUTICS INC | $3,968,000 | -26.1% | 851,400 | 0.0% | 0.22% | -17.5% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $3,902,000 | -31.5% | 279,100 | 0.0% | 0.22% | -23.5% | |
| TCON | TRACON PHARMACEUTICALS INC | $3,619,000 | -24.4% | 517,700 | 0.0% | 0.20% | -15.5% | |
| JUNO | JUNO THERAPEUTICS INC | $3,428,000 | -13.4% | 90,000 | 0.0% | 0.19% | -3.0% | |
| CDTX | CIDARA THERAPEUTICS INC | $3,353,000 | -26.0% | 264,000 | 0.0% | 0.19% | -17.3% | |
| EPZM | New | EPIZYME INC | $3,333,000 | – | 275,000 | +100.0% | 0.19% | – |
| CEMP | CEMPRA INC | $3,239,000 | -43.7% | 184,900 | 0.0% | 0.18% | -37.2% | |
| CHRS | New | COHERUS BIOSCIENCES INC | $3,078,000 | – | 145,000 | +100.0% | 0.17% | – |
| ATRC | ATRICURE INC | $3,029,000 | -25.0% | 180,000 | 0.0% | 0.17% | -16.3% | |
| RGEN | Sell | REPLIGEN CORP | $2,950,000 | -48.4% | 110,000 | -45.5% | 0.16% | -42.3% |
| INCY | New | INCYTE CORP | $2,899,000 | – | 40,000 | +100.0% | 0.16% | – |
| NTUS | Sell | NATUS MEDICAL INC DEL | $2,882,000 | -59.7% | 75,000 | -49.6% | 0.16% | -55.0% |
| VRTX | VERTEX PHARMACEUTICALS INC | $2,750,000 | -36.8% | 34,600 | 0.0% | 0.15% | -29.4% | |
| INSM | INSMED INC | $2,661,000 | -30.2% | 210,000 | 0.0% | 0.15% | -22.0% | |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $2,619,000 | -52.2% | 300,000 | +20.0% | 0.15% | -46.7% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $2,617,000 | -50.9% | 165,000 | 0.0% | 0.15% | -45.3% | |
| IMDZ | IMMUNE DESIGN CORP | $2,340,000 | -35.3% | 180,000 | 0.0% | 0.13% | -27.6% | |
| GLPG | New | GALAPAGOS NVspon adr | $2,175,000 | – | 52,000 | +100.0% | 0.12% | – |
| QURE | UNIQURE NV | $2,078,000 | -28.2% | 174,900 | 0.0% | 0.12% | -20.0% | |
| ZSAN | ZOSANO PHARMA CORP | $2,043,000 | +3.1% | 888,300 | 0.0% | 0.11% | +15.2% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $2,021,000 | -54.8% | 377,000 | 0.0% | 0.11% | -49.6% | |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $1,928,000 | – | 200,000 | +100.0% | 0.11% | – |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $1,935,000 | -7.3% | 150,000 | +50.0% | 0.11% | +3.8% |
| OMED | ONCOMED PHARMACEUTICALS INC | $1,921,000 | -55.1% | 190,000 | 0.0% | 0.11% | -50.0% | |
| New | ACCURAY INC | $1,770,000 | – | 306,200 | +100.0% | 0.10% | – | |
| TNDM | Buy | TANDEM DIABETES CARE INC | $1,366,000 | -25.5% | 156,800 | +1.0% | 0.08% | -17.4% |
| INFI | INFINITY PHARMACEUTICALS INC | $1,300,000 | -32.9% | 246,700 | 0.0% | 0.07% | -24.7% | |
| HTGC | Buy | HERCULES CAPITAL INC | $500,000 | +80.5% | 41,600 | +83.3% | 0.03% | +100.0% |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $462,000 | +81.2% | 9,609 | +79.6% | 0.03% | +100.0% |
| JCI | Buy | JOHNSON CTLS INC | $429,000 | +69.6% | 11,000 | +71.9% | 0.02% | +84.6% |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $419,000 | +56.9% | 16,000 | +36.2% | 0.02% | +76.9% |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $386,000 | +83.8% | 27,500 | +78.6% | 0.02% | +120.0% |
| BBN | BLACKROCK TAX MUNICPAL BD TR | $332,000 | +9.6% | 14,450 | 0.0% | 0.02% | +26.7% | |
| CPPL | Buy | COLUMBIA PIPELINE PARTNERS L | $302,000 | +158.1% | 20,687 | +208.8% | 0.02% | +183.3% |
| NYLD | Buy | NRG YIELD INCcl c | $285,000 | +82.7% | 20,000 | +88.7% | 0.02% | +100.0% |
| BEP | Buy | BROOKFIELD RENEWABLE ENRGY Ppartnership unit | $279,000 | +43.8% | 9,300 | +25.7% | 0.02% | +60.0% |
| ETN | Buy | EATON CORP PLC | $263,000 | +44.5% | 4,200 | +20.0% | 0.02% | +66.7% |
| WELL | Buy | WELLTOWER INC | $250,000 | +83.8% | 3,600 | +80.0% | 0.01% | +100.0% |
| ABB | Buy | ABB LTDsponsored adr | $243,000 | +97.6% | 12,500 | +79.9% | 0.01% | +133.3% |
| ERIC | Buy | ERICSSONadr b sek 10 | $206,000 | +14.4% | 20,500 | +9.6% | 0.01% | +33.3% |
| NSC | Buy | NORFOLK SOUTHERN CORP | $191,000 | +50.4% | 2,300 | +53.3% | 0.01% | +83.3% |
| LPT | Buy | LIBERTY PPTY TRsh ben int | $184,000 | +60.0% | 5,500 | +48.6% | 0.01% | +66.7% |
| BAB | Sell | POWERSHARES ETF TR IIbuild amer etf | $157,000 | -12.8% | 5,211 | -16.1% | 0.01% | 0.0% |
| BG | New | BUNGE LIMITED | $125,000 | – | 2,200 | +100.0% | 0.01% | – |
| GOV | Buy | GOVERNMENT PPTYS INCOME TR | $125,000 | +98.4% | 7,000 | +75.0% | 0.01% | +133.3% |
| SYK | Sell | STRYKER CORP | $107,000 | -11.6% | 1,000 | -23.1% | 0.01% | 0.0% |
| VTR | New | VENTAS INC | $107,000 | – | 1,700 | +100.0% | 0.01% | – |
| APU | New | AMERIGAS PARTNERS L Punit l p int | $109,000 | – | 2,500 | +100.0% | 0.01% | – |
| LXP | Buy | LEXINGTON REALTY TRUST | $109,000 | +75.8% | 12,700 | +64.9% | 0.01% | +100.0% |
| BIP | Sell | BROOKFIELD INFRAST PARTNERSlp int unit | $84,000 | +1.2% | 2,000 | -9.1% | 0.01% | +25.0% |
| New | TESLA MTRS INCnote 0.250% 3/0 | $91,000 | – | 100,000 | +100.0% | 0.01% | – | |
| NATI | Buy | NATIONAL INSTRS CORP | $84,000 | +40.0% | 2,800 | +33.3% | 0.01% | +66.7% |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $65,000 | +3.2% | 2,800 | +7.7% | 0.00% | +33.3% |
| DLR | Sell | DIGITAL RLTY TR INC | $58,000 | -30.1% | 650 | -40.9% | 0.00% | -25.0% |
| SE | Sell | SPECTRA ENERGY CORP | $31,000 | -11.4% | 1,000 | -31.0% | 0.00% | 0.0% |
| TERP | TERRAFORM PWR INC | $40,000 | -31.0% | 4,650 | 0.0% | 0.00% | -33.3% | |
| GLBL | TERRAFORM GLOBAL INCcl a | $21,000 | -57.1% | 8,700 | 0.0% | 0.00% | -50.0% | |
| RMR | Sell | RMR GROUP INCcl a | $1,000 | 0.0% | 37 | -2.6% | 0.00% | – |
| ITC | Exit | ITC HLDGS CORP | $0 | – | -2,300 | -100.0% | -0.00% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -139,300 | -100.0% | -0.07% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -160,600 | -100.0% | -0.07% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -306,200 | -100.0% | -0.10% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -420,500 | -100.0% | -0.33% | – |
| EOG | Exit | EOG RES INC | $0 | – | -144,800 | -100.0% | -0.51% | – |
| SCTY | Exit | SOLARCITY CORP | $0 | – | -615,100 | -100.0% | -1.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.